SBL
GOSS icon

Sargent Bickham Lagudis’s Gossamer Bio GOSS Stock Holding History

Sargent Bickham Lagudis’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$1K – 953
2021
Q1 		$1K Hold
100
– – ﹤0.01% 891
2020
Q4 		$1K Buy
+100
New +$985 ﹤0.01% 835

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Sargent Bickham Lagudis's GOSS Position: Q2 2021 in Review

Sargent Bickham Lagudis sold out of Gossamer Bio (GOSS) in Q2 2021, closing a stake of 100 shares — an estimated $1K sold.

Sargent Bickham Lagudis first reported a position in GOSS in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 115 funds tracked by Wall St. Rank hold GOSS as of Q2 2021.

  • Sargent Bickham Lagudis reported no remaining Gossamer Bio position as of Q2 2021 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 100 Gossamer Bio shares in Q2 2021, an estimated $1K.
  • Sargent Bickham Lagudis first reported a position in Gossamer Bio in Q4 2020 and held it in 2 quarters.
  • Sargent Bickham Lagudis's Gossamer Bio position peaked at $1K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2021, filed 19 Jul 2021.